Could common #HIV drugs reduce the incidence of #AlzheimersDisease ? Penn Medicine IQVIA Sanford Burnham Prebys Learn More Pharmaceuticals MDPI
👉 mdpi.com/1424-8247/17/4…
neurosciencenews.com/alzheimers-hiv…
As global demand for medicine increases, there’s still much work to be done to expand access and ensure medicines reach the patients who will benefit most from them. #STATurday #IQVIAInstitute IQVIA Institute
Learn more: bit.ly/3Jim598
Calling all mid-size and large pharma companies! Join IQVIA’s experts on May 7th for a webinar on global expansion. Explore post-approval #regulatory lifecycle management and local #pharmacovigilance intricacies. Reserve your space: bit.ly/3JiW21F
#drugsafety
🎙️We're soon coming with a new #DisruptionDialogues #Season2 #Podcast #episode with Guy Rachmuth, VP—Corporate Strategy, Enterprise, IQVIA, & Yamini Jain, VP—Healthcare, MarketsandMarkets™. Join us to unravel various #tech transformations in #healthcare . Stay tuned for more!
#biopharma industry's #M &A focus in Q4 2023 was primarily on oncology, but we expect neurology and cardiometabolic indications to gain traction in 2024. Explore the insights into these therapeutic area trends #PharmaDeals #StrategicAcquisitions bit.ly/49JB8DF
IQVIA Institute’s latest report finds that health care systems’ infrastructure and the complexities of the patient journey pose significant barriers to the future success and sustainability of these treatments. To learn more: bit.ly/4cXkxis #PharmaDeals